Salmonella outbreak: Recalled eggs sold at Walmart, Safeway, and elsewhere sicken people in 7 states
A significant recall of 1.7 million dozen eggs is underway. The eggs were believed to be the source of a salmonella outbreak that has sickened dozens of people across seven states and so far led to 21 people being hospitalized. They were distributed to several major retailers, including Walmart and Safeway. Here's what you need to know about the recall and outbreak.
Shell eggs recalled due to salmonella fears
On June 6, the August Egg Company of Hilmar, California, issued a voluntary recall of 1.7 million dozen eggs produced at its facilities. The company initiated the recall after it discovered that the eggs are feared to have been contaminated with salmonella, a potentially deadly bacterium.
On the same day, the U.S. Food and Drug Administration (FDA) published August Egg Company's recall notice on its website, while the U.S. Centers for Disease Control and Prevention (CDC) announced an investigation into a multistate outbreak of salmonella linked to eggs.
Dozens sickened and hospitalized across 7 states
The CDC's investigation has found that eggs produced by August Egg Company are linked to dozens of cases of people becoming ill after consuming them.
The agency's latest data shows that there are so far 79 cases linked to the August Egg Company's recalled products. Of those cases, 21 have resulted in hospitalizations. Thankfully, no deaths have been reported so far.
The cases are spread across seven states: Arizona, California, Kentucky, Nebraska, New Jersey, Nevada, and Washington.
Of those states, California has the most number of cases, at 63, followed by Washington and Nevada, with four cases each. Arizona has had three cases, Nebraska and New Jersey two cases, and Kentucky has one.
However, many people who become sick with salmonella see their symptoms resolve without contacting a health professional, so the actual number of cases could be higher.
When and where were the eggs distributed?
According to the notice posted on the FDA's website, the recalled eggs were distributed between February and May. The retail locations that received the eggs include:
Walmart
Save Mart
FoodMaxx
Lucky
Smart & Final
Safeway
Raleys
Food 4 Less
Ralphs
The eggs were distributed between February 3 and May 15, 2025, to Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less, and Ralphs locations in California and Nevada. Those eggs had sell-by dates ranging from March 4 to June 4, 2025.
The eggs were also distributed between February 3 through May 6, 2025, to Walmart stores in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois. Those eggs had sell-by dates ranging from March 4 to June 19, 2025.
What eggs are included in the recall?
Over two dozen egg products packaged under multiple brands are included in the recall. The recall notice states that the eggs were packaged in fiber or plastic cartons and have a plant code number P-6562 or CA5330 with the Julian Dates between 32 to 126.
Photographs of the cartons can be found here.
The item names of the egg products included in the recall, along with their plant number and carton UPC are:
Item Name Plant Number Carton UPC
Clover Organic Large Brown 12 eggs P-6562 or CA-5330 070852010427
First Street Cage Free Large Brown Loose 1 case=150 eggs P-6562 or CA-5330 041512039638
Nulaid Medium Brown Cage Free 12 eggs P-6562 or CA-5330 071230021042
Nulaid Jumbo Brown Cage Free 12 eggs P-6562 or CA-5330 071230021011
O Organics Cage Free Large Brown 6 eggs P-6562 or CA-5330 079893401522
O Organics Large Brown 12 eggs P-6562 or CA-5330 079893401508
O Organics Large Brown 18 eggs P-6562 or CA-5330 079893401546
Marketside Organic Large Cage Free Brown 12 eggs P-6562 or CA-5330 681131122771
Marketside Organic Large Cage Free Brown 18 eggs P-6562 or CA-5330 681131122801
Marketside Large Cage Free Brown 12 eggs P-6562 or CA-5330 681131122764
Marketside Large Cage Free Brown 18 eggs P-6562 or CA-5330 681131122795
Raley's Large Cage Free Brown 12 eggs P-6562 or CA-5330 046567033310
Raley's Large Cage Free Brown 18 eggs P-6562 or CA-5330 046567040325
Raley's Organic Large Cage Free Brown 12 eggs P-6562 or CA-5330 046567028798
Raley's Organic Large Cage Free Brown 18 eggs P-6562 or CA-5330 046567040295
Simple Truth Medium Brown Cage Free 18 eggs P-6562 or CA-5330 011110099327
Simple Truth Large Brown Cage Free 18 eggs P-6562 or CA-5330 011110873743
Sun Harvest Organic Cage Free Large Brown 12 eggs P-6562 or CA-5330 041512131950
Sun Harvest Organic Cage Free Large Brown 18 eggs P-6562 or CA-5330 041512145162
Sunnyside Large Brown Cage Free 12 eggs P-6562 or CA-5330 717544211747
Sunnyside Large Brown Cage Free 18 eggs P-6562 or CA-5330 717544211754
Sunnyside Organic Cage Free Large Brown 12 eggs P-6562 or CA-5330 717544201441
Sunnyside Organic Cage Free Large Brown 18 eggs P-6562 or CA-5330 717544211761
Loose Small Brown Cage Free-1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA
Loose Medium Brown Cage Free -1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA
Loose Medium Brown Organic -1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA
Loose Large Brown Organic-1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA
Loose Jumbo Brown Cage Free -1 box=5 flats(1 flat=20 eggs) P-6562 or CA-5330 NA
Loose Jumbo Brown Organic -1 box=5 flats(1 flat=20 eggs) P-6562 or CA-5330 NA
What is Salmonella?
Salmonella is a potentially deadly bacterium that is usually contracted after eating contaminated foods.
The CDC says that typical symptoms of a salmonella infection include diarrhea, fever, and stomach cramps, which typically present between six hours and six days after exposure to the bacteria.
Typical salmonella infections last between four and seven days, and most people recover without treatment. However, salmonella infections can also cause severe illness in individuals, especially those who are younger than five, older than 65, or have weakened immune systems.
What should I do if I have the recalled eggs?
According to the CDC, if you have the recalled eggs in your possession, you should not consume them.
Instead, you should throw the eggs out or return them to their place of purchase for a refund. You should also sanitize all surfaces that may have come into contact with the eggs.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
an hour ago
- Indianapolis Star
Jaguar Health Provides Update on Meeting with FDA Discussing Statistically Significant Results of Responder Analysis of Breast Cancer Patients in Phase 3 OnTarget Trial and Potential Approval Pathway for Crofelemer
Productive and collaborative discussion on proposed pathway by the company to bring crofelemer to approval for cancer therapy-related diarrhea (CTD) in patients with metastatic breast cancer receiving selected targeted therapies The currently estimated US metastatic breast cancer population would qualify as an orphan population, which aligns with company's core focus on orphan diseases Company plans to promptly pursue authorization to initiate expanded access program for patients with breast cancer who may not be eligible for a potential pivotal treatment trial with crofelemer in patients with metastatic breast cancer SAN FRANCISCO, CA / ACCESS Newswire / June 9, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today provided a recap on the company's assessment of the in-person Type C Meeting on May 28, 2025 with the Division of Gastroenterology of the U.S. Food and Drug Administration (FDA) to discuss the statistically significant responder analysis results for adult patients with breast cancer in Napo's recently conducted Phase 3 OnTarget trial. 'We were very happy to take part in the face-to-face Type C Meeting, the catalyst for which was the positive data in the subpopulation of breast cancer patients from our OnTarget trial,' said Lisa Conte, Jaguar's founder, president, and CEO. 'Napo proposed two simultaneous potential pathways during the meeting for making crofelemer available to metastatic breast cancer patients with the significant unmet medical need of CTD: conducting a pivotal treatment trial to facilitate approval of crofelemer for CTD in this focused patient population; and the prompt pursuit of authorization to initiate an expanded access program for breast cancer patients with CTD who may not be eligible for this study, including breast cancer patients in the adjuvant and neoadjuvant settings. We are pleased with the constructive and productive discussion that took place with the FDA during the meeting. Last week the FDA formally acknowledged both of these key discussion points in correspondence to Napo. We plan to submit a protocol to the FDA for a pivotal treatment trial for a smaller number of metastatic breast cancer patients using crofelemer.' Patient advocates participated in the Type C Meeting to share their raw and personal experience with CTD, including a metastatic breast cancer patient with uncontrollable diarrhea who received a prescription for crofelemer. 'The design of the protocol for OnTarget was based on a survey of cancer patients. Today there are close to 100 approved targeted cancer agents. Thanks to these amazing drugs, metastatic cancer patients are living longer, frequently rendering cancer, and CTD, chronic ailments with which to live. To deepen our understanding of the current population of metastatic cancer breast with CTD, and ensure the clinical meaningfulness of the design of the anticipated pivotal treatment trial, we plan to conduct a new survey of this cancer patient population,' Conte said. The currently estimated US metastatic breast cancer population potentially qualifies as an orphan population, in alignment with the company's core focus on orphan diseases. The company therefore intends to request orphan drug designation from the FDA for the CTD indication in this population. Given crofelemer's novel and paradigm-shifting mechanism of action, the company also plans to seek Breakthrough Therapy designation and/or Fast Track designation from the FDA to support potentially expedited regulatory approval in the US for crofelemer for CTD in metastatic breast cancer patients. 'Embracing a sharp strategic focus on orphan indications seems to fit with the new administration's efforts and philosophy,' said Conte. 'Dr. Marty Makary, the new Commissioner of the FDA, commented in April 2025 that the agency will open a new regulatory pathway based on what he called a 'plausible mechanism,' focusing mainly on rare or incurable diseases.' As expressed during the Type C Meeting, the data from the first-of-its-kind prophylactic OnTarget study is invaluable, providing new insights into the natural history of the important and debilitating side effect of CTD. Diarrhea is a common side effect of targeted cancer therapies and can lead to dose changes, treatment delays, and often cessation of lifesaving cancer therapy. The benefit to risk ratio of crofelemer is well-documented, as the active agent has been commercialized for the approved indication of HIV-related diarrhea since 2012, with no crofelemer-related reported serious adverse events. In both the US and European Union, crofelemer has been granted orphan drug designation for the orphan diseases of short bowel syndrome with intestinal failure and microvillus inclusion disease. Crofelemer has been granted orphan drug designation for treatment of diarrhea in cholera in the US, where cholera is an orphan disease. Orphan drug designation in the US qualifies the sponsor of a drug for various development incentives, including tax credits for qualified clinical testing and relief of filing fees. Additionally, orphan drug designation in the US provides a seven-year period of marketing exclusivity to the first sponsor who obtains marketing approval for the designated orphan drug. While the multicenter, double-blind, placebo-controlled OnTarget pivotal trial did not meet its primary endpoint, the subgroup of adult breast cancer patients achieved statistically significant results in the responder analysis. In the responder analysis of patients with breast cancer on targeted therapies, crofelemer CTD prophylaxis resulted in a greater proportion of monthly responders of diarrhea improvement compared to placebo. Patients with breast cancer accounted for 183 of the 287 participants in this unprecedented prophylactic clinical trial of crofelemer for diarrhea in adults with 10 solid tumor types receiving targeted therapy with or without standard chemotherapy. The OnTarget results in breast cancer patients were the subject of a poster presentation on December 11, 2024, at the San Antonio Breast Cancer Symposium, and additional significant results in adult breast cancer patients from the OnTarget study have been accepted for presentation as an oral rapid e-poster at the Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting in June 2025 in Seattle, Washington. About Crofelemer Crofelemer is a novel, oral plant-based prescription medicine purified from the red bark sap, also referred to as 'dragon's blood,' of the Croton lechleri tree in the Amazon Rainforest. Napo has established a sustainable harvesting program, under fair trade practices, for crofelemer to ensure a high degree of quality, ecological integrity, and support for indigenous communities. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi ® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute 'forward-looking statements.' These include statements regarding Jaguar's expectation that the currently estimated US metastatic breast cancer population qualifies as an orphan population, Jaguar's expectation that the company will submit a protocol to the FDA for a pivotal treatment trial for a smaller number of metastatic breast cancer patients using crofelemer, Jaguar's expectation that it will promptly pursue authorization to initiate an expanded access program for patients with breast cancer who may not be eligible for a potential pivotal treatment trial with crofelemer in patients with metastatic breast cancer patients, and that the expanded access program would potentially include breast cancer patients in the adjuvant and neoadjuvant settings, Jaguar's expectation that Napo will conduct a clinical trial of crofelemer for treatment of CTD in patients with metastatic breast cancer, Jaguar's plans to seek Breakthrough Therapy designation and/or Fast Track designation from the FDA to support potentially expedited regulatory approval in the US for crofelemer for CTD in metastatic breast cancer patients, and Jaguar's expectation that additional significant results in adult breast cancer patients from the OnTarget study will be presented at the 2025 MASCC Annual Meeting. In some cases, you can identify forward-looking statements by terms such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'aim,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'contemplate,' 'believe,' 'estimate,' 'predict,' 'potential' or 'continue' or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact: hello@ Jaguar-JAGX SOURCE: Jaguar Health, Inc. View the original press release on ACCESS Newswire
WebMD
an hour ago
- WebMD
Sinus Headache … Or Is It?
For many years, I thought I had all the headaches of the rainbow. Migraine? Yes. Tension? Absolutely. Sinus? Without fail. Add in the headaches you get during a major bout with a cold, flu, or COVID, and I pretty much thought I had a degree in headaches. My medicine cabinet also represented the many treatments for any type of headache on any given day. I often smiled, knowing I would have something to barter in the apocalypse. I'd be the medicine woman trading Tylenol PMs for bread! Now let's be clear, I've been that chick! From an early age, I was the one who (when I was old enough to do so) had headache medication for anyone who needed it. I felt valuable being able to help someone escape a pain that I was all too familiar with. This system has made me a little scattered when planning, especially for travel. I've had to make sure I have my prescription migraine medication, some type of painkiller for a 'regular' headache, some sinus headache medication if we're talking March through early June, and then again in late September through early November. Right when the fall allergy season ends, I'm armed with headache medication for the cold and flu season. I'll also improvise when I need to. In the past, if I'd been caught off guard with what I believed to be a sinus headache, I'd take a Tylenol and then some generic sinus medication or do a neti pot. The goal was to attack it from the side if I couldn't attack it head-on. But as things commonly go with me and migraine, I learned something new recently that blew my mind. I was speaking to a neurologist about migraine (shout-out to Dr. Paul Mathew), and he said, 'You know, many people will think they're having a sinus or tension headache when it's actually a migraine.' Wait, what?! You mean all of these years, I've been walking around with an entire drugstore in my purse for no reason? But being a natural skeptic, I had to look it up myself. Sure enough, studies show that 90% of self-diagnosed sinus headaches are migraine attacks. I hate to be known as someone who follows the crowd, but dang it, I've been living in that 90%! For years, I wondered why traditional sinus medications would do nothing for my sinus headaches. I'd up the dose, I'd switch brands. I'd take a steam shower. I'd do all the things! Still, my 'sinus' headache would hang around for days. I'd be miserable. I'd call out of work sometimes. I'd be bedridden for days sometimes. I hated the spring. All along, I was dealing with a migraine. Honestly, I should have known. I mean, I had the classic migraine symptoms – sensitivity to light, nausea … oh, the nausea! I used to walk around God's green earth telling other people that my sinus headaches felt 'a lot like a migraine.' It's almost funny now. Almost. Beyond sounding very headache illiterate, the worst part of it all was that I was delaying my treatment. I was suffering for days sometimes, never once glancing at my migraine medication. But if you've been confused like me about how sinus and migraine headaches are different, don't feel bad. It seems they can have similar symptoms and triggers. Changes in weather and seasons can trigger both migraine attacks and sinus headaches. Both can have pain behind the eyes. Both can have a runny nose and watery eyes. It's no wonder most of us get it wrong when it comes to these types of headaches. The same nerves are involved in the face, mouth, jaw, head, and sinuses. But I've been reading that sinus headaches are pretty rare. We're nose-deep in allergy season where I live. Thankfully, I'm not in a place where yellow pollen covers the cars anymore, but the dry (sometimes dusty) air can kick up all kinds of allergens. All I know is I used to hate the spring and all its flowery-ness. I would gear up for days – sometimes weeks – of what I now know are migraine attacks. But as the old folks say: 'When you know better, you do better.' Now, when I feel a migraine attack coming on, I will treat it as such … and quickly! After all, there are roses to smell and long days to enjoy.
WebMD
an hour ago
- WebMD
How Aging Affects Your Gut
With age comes wisdom. But it also comes with some not-so-welcome developments, like more moments of forgetfulness, more aches and pains – and, often, more digestive woes. Here are some of the most common issues and what you can do to feel better. Constipation Most people will experience constipation at one time or another. But as you age, it can happen more frequently. Your digestive tract may start to move more slowly, and waste that sits in your intestines for too long can dry out and become hard to pass. You may also be taking more medications, some of which could cause constipation. Being less active and drinking fewer fluids both increase the likelihood, too. What to do: Be sure you're staying well-hydrated, getting exercise, and including fiber-rich foods in your meals and snacks every day. If you're still having trouble, ask your doctor about trying a daily fiber supplement like psyllium or a laxative. Food Intolerances Are there foods you happily ate in the past that are now giving you grief? Production of some digestive enzymes can decline with age. For instance, older adults tend to make less lactase, the enzyme that breaks down the lactose in milk, so you may not tolerate dairy products as well. It's even possible to develop celiac disease (the inability to digest gluten) and food allergies as you get older. What to do: Jot down what you eat and drink as well as your symptoms for a couple of weeks to see if you can spot patterns. Always see your doctor if you think you're experiencing allergic symptoms such as vomiting, hives, or itching. Heartburn Muscle tone can weaken with age, and that includes the sphincter between your stomach and esophagus. When that valve weakens, acid from the stomach can splash up into the esophagus and cause the telltale burning sensation. If you've gained weight with age, that ups your risk of heartburn, too. What to do: Eat smaller, more frequent meals instead of a few large ones (an overfull belly can cause that sphincter to become relaxed). Take an after-meal walk and avoid eating right before bed. Pay attention to whether any of these trigger foods may be bothering you: caffeine and carbonated drinks, alcohol, spicy or greasy foods, chocolate, mint, tomatoes and tomato products, and citrus fruits.
